Article Text

Download PDFPDF
Strontium and cardiovascular events
  1. Mark J Bolland,
  2. Andrew Grey
  1. Department of Medicine, University of Auckland, Auckland, New Zealand
  1. Correspondence to Mark J Bolland, Department of Medicine, University of Auckland, Auckland 1142, New Zealand; m.bolland{at}

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

In the report of their trial of strontium ranelate in knee osteoarthritis, Reginster and colleagues state ‘Strontium ranelate was well tolerated’, and ‘The safety profile of strontium ranelate was satisfactory, in line …

View Full Text


  • Competing interests None.

  • Provenance and peer review Not commissioned; internally peer reviewed.

Linked Articles